Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.8031
+0.0431 (5.67%)
At close: Apr 2, 2025, 4:00 PM
0.7950
-0.0081 (-1.01%)
After-hours: Apr 2, 2025, 5:03 PM EDT

Milestone Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-41.52-59.69-58.39-42.85-49.97
Upgrade
Depreciation & Amortization
0.650.60.480.360.38
Upgrade
Other Amortization
0.370.24---
Upgrade
Loss (Gain) From Sale of Assets
0.01-0.14--
Upgrade
Loss (Gain) From Sale of Investments
-0.45-0.16-0.1--
Upgrade
Stock-Based Compensation
5.789.539.057.284.95
Upgrade
Other Operating Activities
2.671.8-0.39-0.27-0.28
Upgrade
Change in Accounts Receivable
1.72-2.33-0.760.10.04
Upgrade
Change in Accounts Payable
0.881.04-0.910.64-2.08
Upgrade
Change in Other Net Operating Assets
1.062.53-1.61.52-3.76
Upgrade
Operating Cash Flow
-28.85-46.42-52.47-33.22-50.73
Upgrade
Capital Expenditures
-0.03-0.11-0.27--
Upgrade
Investment in Securities
8.324.87-56.8570-70
Upgrade
Investing Cash Flow
8.284.76-57.1270-70
Upgrade
Long-Term Debt Issued
-50---
Upgrade
Net Debt Issued (Repaid)
-50---
Upgrade
Issuance of Common Stock
27.50.583.090.1225.22
Upgrade
Other Financing Activities
4.62-2.79-4.9348.01
Upgrade
Financing Cash Flow
32.1247.793.095.0673.22
Upgrade
Net Cash Flow
11.556.12-106.5141.83-47.51
Upgrade
Free Cash Flow
-28.88-46.54-52.74-33.22-50.73
Upgrade
Free Cash Flow Margin
--4653.60%-1054.82%-221.49%-
Upgrade
Free Cash Flow Per Share
-0.46-1.08-1.24-0.79-1.73
Upgrade
Levered Free Cash Flow
-18.12-28.29-31.36-17.05-32.15
Upgrade
Unlevered Free Cash Flow
-16.25-26.94-31.36-17.05-32.15
Upgrade
Change in Net Working Capital
-3.67-1.233.34-2.235.78
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q